Takeda Pharmaceutical (TAK) Inventory Average (2018 - 2026)
Takeda Pharmaceutical (TAK) posted quarterly Inventory Average of $9.0 billion for Q2 2026, up 8.65% year-over-year from $8.3 billion in Q2 2025, and little changed quarter-over-quarter from $9.0 billion in Q1 2026.
Takeda Pharmaceutical (TAK) Inventory Average (2018 - 2026) Analysis & Trends
Takeda Pharmaceutical's Inventory Average history runs 9 years deep, the most recent figure standing at $9.0 billion for Q2 2026.
- In Q2 2026, Inventory Average rose 8.65% year-over-year to $9.0 billion; the TTM figure through Jun 2026 stood at $9.0 billion (up 8.65% YoY), while the FY2026 annual figure was $8.6 billion, up 5.42% from the prior year.
- Inventory Average for Q2 2026 stood at $9.0 billion, roughly flat from $9.0 billion in the prior quarter.
- The five-year high for Inventory Average was $9.0 billion in Q1 2026, with the low at $6.7 billion in Q4 2022.
- The 5-year median for Inventory Average is $8.1 billion (2024), against an average of $8.0 billion.
- The sharpest annual moves came in 2022 and 2023: Inventory Average slipped 5.52% in 2022, then grew 18.19% in 2023.
- Takeda Pharmaceutical's Inventory Average stood at $6.7 billion in 2022, then advanced by 18.19% to $8.0 billion in 2023, then climbed by 2.33% to $8.1 billion in 2024, then gained by 10.29% to $9.0 billion in 2025, then gained by 0.13% to $9.0 billion in 2026.
- Business Quant data shows TAK's Inventory Average at $9.0 billion in Q2 2026, $9.0 billion in Q1 2026, and $9.0 billion in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | 1.41 Bn |
| 2 | Teva Pharmaceutical Industries | 43.42 Bn | 39.76 Bn | 2.15 Bn | 3.20 Bn |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn | 2.56 Bn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.98 Bn | 5.10 Bn | 8.99 Bn |
| 5 | United Therapeutics | 22.29 Bn | 19.63 Bn | 683.80 Mn | 186.05 Mn |
| 6 | Viatris | 18.78 Bn | 17.89 Bn | 1.46 Bn | 3.93 Bn |
| 7 | Neurocrine Biosciences | 15.66 Bn | 15.27 Bn | 935.80 Mn | 84.35 Mn |
| 8 | Elanco Animal Health | 11.91 Bn | 11.38 Bn | 798.00 Mn | 1.74 Bn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | 824.00 Mn |
| 10 | Alkermes | 8.20 Bn | 7.55 Bn | 397.90 Mn | 317.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 8.99 Bn |
| Mar 31, 2026 | 9.02 Bn |
| Dec 31, 2025 | 8.98 Bn |
| Sep 30, 2025 | 8.70 Bn |
| Jun 30, 2025 | 8.28 Bn |
| Mar 31, 2025 | 8.09 Bn |
| Dec 31, 2024 | 8.14 Bn |
| Sep 30, 2024 | 8.14 Bn |
| Jun 30, 2024 | 8.18 Bn |
| Mar 31, 2024 | 8.04 Bn |
| Dec 31, 2023 | 7.96 Bn |
| Sep 30, 2023 | 7.95 Bn |
| Jun 30, 2023 | 7.68 Bn |
| Mar 31, 2023 | 7.01 Bn |
| Dec 31, 2022 | 6.73 Bn |
| Sep 30, 2022 | 7.04 Bn |
| Jun 30, 2022 | 7.26 Bn |
| Mar 31, 2022 | 7.24 Bn |
| Dec 31, 2021 | 7.13 Bn |
| Sep 30, 2021 | 7.12 Bn |